A Study on Impact of Canagliflozin on Health Status, Quality of Life, and Functional Status in Heart Failure
Clinical trial NCT04252287 · COMPLETED
Trial details
- NCT number
- NCT04252287
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2021-11-09
- Enrollment
- 476
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.